<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36016091</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Early Emergence of 5' Terminally Deleted Coxsackievirus-B3 RNA Forms Is Associated with Acute and Persistent Infections in Mouse Target Tissues.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1203</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10081203</ELocationID><Abstract><AbstractText>Major EV-B populations characterized by 5′ terminal deletions (5′TD) have been shown to be associated with the development of myocarditis and type 1 diabetes in mice or humans. To date, the dynamics of EV-B 5′TD-RNA forms’ emergence during the course of infection and their impact on cellular functions remain unclear. Using a RACE-PCR approach in CVB3/28-infected mouse organs, we showed an early (3 days post infection, DPI) emergence of major 5′TD populations associated with minor full-length RNA forms. Viral replication activities with infectious particle production were associated with heart, liver, and pancreas acute inflammatory lesions, whereas clearance of viral RNA without organ lesions was observed in the brain, lung, intestines, and muscles from 3 to 7 DPI. At 28 DPI, low viral RNA levels, +/-RNA ratios &lt; 5 associated with viral protein 1 expression revealed a persistent infection in the heart and pancreas. This persistent infection was characterized by molecular detection of only 5′TD RNA forms that were associated with dystrophin cleavage in the heart and insulin production impairment in beta-pancreatic cells. These results demonstrated that major EV-B 5′TD RNA forms can be early selected during systemic infection and that their maintenance may drive EV-induced acute and persistent infections with target cell dysfunctions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callon</LastName><ForeName>Domitille</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2443-1684</Identifier><AffiliationInfo><Affiliation>Cardiovir EA-4684, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathology Department, CHU Reims, Hôpital Robert Debré, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreil</LastName><ForeName>Anne-Laure</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Cardiovir EA-4684, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouland</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratoire d'Anatomie Pathologique, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fichel</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1793-6107</Identifier><AffiliationInfo><Affiliation>Laboratoire d'Anatomie Pathologique, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fornès</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovir EA-4684, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathology Department, CHU Reims, Hôpital Robert Debré, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreoletti</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiovir EA-4684, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Virology Department, CHU Reims, Hôpital Robert Debré, 51100 Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berri</LastName><ForeName>Fatma</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1717-4667</Identifier><AffiliationInfo><Affiliation>Cardiovir EA-4684, UFR Médecine, Université de Reims Champagne-Ardenne, 51100 Reims, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019 dotation</GrantID><Agency>Fédération française de cardiologie</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5′ terminal genomic deletion</Keyword><Keyword MajorTopicYN="N">DBA/2J mouse</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">persistent</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36016091</ArticleId><ArticleId IdType="pmc">PMC9413645</ArticleId><ArticleId IdType="doi">10.3390/vaccines10081203</ArticleId><ArticleId IdType="pii">vaccines10081203</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The Life Cycle of Non-Polio Enteroviruses and How to Target It. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Genoni A., Canducci F., Rossi A., Broccolo F., Chumakov K., Bono G., Salerno-Uriarte J., Salvatoni A., Pugliese A., Toniolo A. Revealing Enterovirus Infection in Chronic Human Disorders: An Integrated Diagnostic Approach. Sci. Rep. 2017;7:5013. doi: 10.1038/s41598-017-04993-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04993-y</ArticleId><ArticleId IdType="pmc">PMC5504018</ArticleId><ArticleId IdType="pubmed">28694527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S., Smithee S., Alhazmi A., Chapman N. Coxsackievirus Can Persist in Murine Pancreas by Deletion of 5′ Terminal Genomic Sequences: Coxsackievirus Persistence in the Pancreas. J. Med. Virol. 2015;87:240–247. doi: 10.1002/jmv.24039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24039</ArticleId><ArticleId IdType="pubmed">25111164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam P.E., Fontana D.R., Messner R.P. Coxsackievirus B1–Induced Chronic Inflammatory Myopathy: Differences in Induction of Autoantibodies to Muscle and Nuclear Antigens by Cloned Myopathic and Amyopathic Viruses. J. Lab. Clin. Med. 2003;142:196–204. doi: 10.1016/S0022-2143(03)00108-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2143(03)00108-2</ArticleId><ArticleId IdType="pubmed">14532908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N.M., Kim K.-S., Drescher K.M., Oka K., Tracy S. 5′ Terminal Deletions in the Genome of a Coxsackievirus B2 Strain Occurred Naturally in Human Heart. Virology. 2008;375:480–491. doi: 10.1016/j.virol.2008.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.02.030</ArticleId><ArticleId IdType="pmc">PMC2440640</ArticleId><ArticleId IdType="pubmed">18378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A., Nguyen Y., Wehbe M., Renois F., Fornes P., Bani-Sadr F., Metz D., Andreoletti L. Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues. Emerg. Infect. Dis. 2016;22:1488–1490. doi: 10.3201/eid2208.160186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2208.160186</ArticleId><ArticleId IdType="pmc">PMC4982168</ArticleId><ArticleId IdType="pubmed">27434549</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A., Gretteau P.-A., Wehbe M., Renois F., N’Guyen Y., Leveque N., Vu M.N., Tracy S., Chapman N.M., Bruneval P., et al. Enterovirus Persistence in Cardiac Cells of Patients Suffering From Idiopathic Dilated Cardiomyopathy Is Linked to 5’ Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Circulation. 2019;139:2326–2338. doi: 10.1161/CIRCULATIONAHA.118.035966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S., Tracy S., Tapprich W., Bailey J., Lee C.-K., Kim K., Barry W.H., Chapman N.M. 5’-Terminal Deletions Occur in Coxsackievirus B3 during Replication in Murine Hearts and Cardiac Myocyte Cultures and Correlate with Encapsidation of Negative-Strand Viral RNA. J. Virol. 2005;79:7024–7041. doi: 10.1128/JVI.79.11.7024-7041.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7024-7041.2005</ArticleId><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N., Garcia M., Bouin A., Nguyen J.H.C., Tran G.P., Andreoletti L., Semler B.L. Functional Consequences of RNA 5′-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation. J. Virol. 2017;91:e00423-17. doi: 10.1128/JVI.00423-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00423-17</ArticleId><ArticleId IdType="pmc">PMC5533909</ArticleId><ArticleId IdType="pubmed">28539455</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing Enterovirus-Induced Myocarditis Is Associated with Persistent Heart Muscle Infection: Quantitative Analysis of Virus Replication, Tissue Damage, and Inflammation. Proc. Natl. Acad. Sci. USA. 1992;89:314–318. doi: 10.1073/pnas.89.1.314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.1.314</ArticleId><ArticleId IdType="pmc">PMC48227</ArticleId><ArticleId IdType="pubmed">1309611</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M., N’Guyen Y., Mirand A., Henquell C., Lebreil A.-L., Berri F., Bani-Sadr F., Lina B., Schuffenecker I., Andreoletti L. Major 5′terminally Deleted Enterovirus Populations Modulate Type I IFN Response in Acute Myocarditis Patients and in Human Cultured Cardiomyocytes. Sci. Rep. 2020;10:11947. doi: 10.1038/s41598-020-67648-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67648-5</ArticleId><ArticleId IdType="pmc">PMC7371739</ArticleId><ArticleId IdType="pubmed">32686697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.-S., Chapman N.M., Tracy S. Replication of Coxsackievirus B3 in Primary Cell Cultures Generates Novel Viral Genome Deletions. J. Virol. 2008;82:2033–2037. doi: 10.1128/JVI.01774-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01774-07</ArticleId><ArticleId IdType="pmc">PMC2258713</ArticleId><ArticleId IdType="pubmed">18057248</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M., Heng L., Callon D., Lebreil A.-L., Gretteau P.-A., Nguyen Y., Berri F., Andreoletti L. Structures and Functions of Viral 5′ Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections. Viruses. 2020;12:919. doi: 10.3390/v12090919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090919</ArticleId><ArticleId IdType="pmc">PMC7552046</ArticleId><ArticleId IdType="pubmed">32839386</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Olagnier D., Chiang C., van de Winkel R., van Essen P., Zoll J., Hiscott J., van Kuppeveld F.J.M. Coxsackievirus Cloverleaf RNA Containing a 5′ Triphosphate Triggers an Antiviral Response via RIG-I Activation. PLoS ONE. 2014;9:e95927. doi: 10.1371/journal.pone.0095927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095927</ArticleId><ArticleId IdType="pmc">PMC3997492</ArticleId><ArticleId IdType="pubmed">24759703</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., Hur S., Semler B.L., van Rij R.P., van Kuppeveld F.J.M. MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells. Cell Rep. 2012;2:1187–1196. doi: 10.1016/j.celrep.2012.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cathcart A.L., Rozovics J.M., Semler B.L. Cellular MRNA Decay Protein AUF1 Negatively Regulates Enterovirus and Human Rhinovirus Infections. J. Virol. 2013;87:10423–10434. doi: 10.1128/JVI.01049-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-13</ArticleId><ArticleId IdType="pmc">PMC3807403</ArticleId><ArticleId IdType="pubmed">23903828</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Yang X., Zhao Z., Liu X., Zhang W. Host Restriction Factor A3G Inhibits the Replication of Enterovirus D68 by Competitively Binding the 5’ Untranslated Region with PCBP1. J. Virol. 2022;96:e0170821. doi: 10.1128/JVI.01708-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01708-21</ArticleId><ArticleId IdType="pmc">PMC8791300</ArticleId><ArticleId IdType="pubmed">34730395</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Mar K.B., Sari L., Gaszek I.K., Cheng Q., Evers B.M., Shelton J.M., Wight-Carter M., Siegwart D.J., Lin M.M., et al. TRIM7 Inhibits Enterovirus Replication and Promotes Emergence of a Viral Variant with Increased Pathogenicity. Cell. 2021;184:3410–3425.e17. doi: 10.1016/j.cell.2021.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Z., Chapman N.M., Hufnagel G., Tracy S., Romero J.R., Barry W.H., Zhao L., Currey K., Shapiro B. The Cardiovirulent Phenotype of Coxsackievirus B3 Is Determined at a Single Site in the Genomic 5’ Nontranslated Region. J. Virol. 1995;69:4607–4618. doi: 10.1128/jvi.69.8.4607-4618.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.8.4607-4618.1995</ArticleId><ArticleId IdType="pmc">PMC189260</ArticleId><ArticleId IdType="pubmed">7609025</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Aguilera B., Banner J., Cohle S., d’Amati G., de Gouveia R.H., di Gioia C., Fabre A., Gallagher P.J., Leone O., et al. Guidelines for Autopsy Investigation of Sudden Cardiac Death: 2017 Update from the Association for European Cardiovascular Pathology. Virchows Arch. 2017;471:691–705. doi: 10.1007/s00428-017-2221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-017-2221-0</ArticleId><ArticleId IdType="pmc">PMC5711979</ArticleId><ArticleId IdType="pubmed">28889247</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio A.L.P., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B., Fu M., Helio T., Heymans S., Jahns R., et al. Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Myocarditis: A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34:2636–2648. doi: 10.1093/eurheartj/eht210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Andréoletti L., Hober D., Becquart P., Belaich S., Copin M.C., Lambert V., Wattré P. Experimental CVB3-Induced Chronic Myocarditis in Two Murine Strains: Evidence of Interrelationships between Virus Replication and Myocardial Damage in Persistent Cardiac Infection. J. Med. Virol. 1997;52:206–214. doi: 10.1002/(SICI)1096-9071(199706)52:2&lt;206::AID-JMV15&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199706)52:2&lt;206::AID-JMV15&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">9179770</ArticleId></ArticleIdList></Reference><Reference><Citation>N’Guyen Y., Lesaffre F., Metz D., Tassan S., Saade Y., Boulagnon C., Fornes P., Renois F., Andreoletti L. Enterovirus but Not Parvovirus B19 Is Associated with Idiopathic Dilated Cardiomyopathy and Endomyocardial CD3, CD68, or HLA-DR Expression. J. Med. Virol. 2017;89:55–63. doi: 10.1002/jmv.24600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24600</ArticleId><ArticleId IdType="pubmed">27301802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque N., Renois F., Talmud D., Nguyen Y., Lesaffre F., Boulagnon C., Bruneval P., Fornes P., Andréoletti L. Quantitative Genomic and Antigenomic Enterovirus RNA Detection in Explanted Heart Tissue Samples from Patients with End-Stage Idiopathic Dilated Cardiomyopathy. J. Clin. Microbiol. 2012;50:3378–3380. doi: 10.1128/JCM.01612-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01612-12</ArticleId><ArticleId IdType="pmc">PMC3457437</ArticleId><ArticleId IdType="pubmed">22837323</ArticleId></ArticleIdList></Reference><Reference><Citation>Escarmís C., Dopazo J., Dávila M., Palma E.L., Domingo E. Large Deletions in the 5′-Untranslated Region of Foot-and-Mouth Disease Virus of Serotype C. Virus Res. 1995;35:155–167. doi: 10.1016/0168-1702(94)00091-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(94)00091-P</ArticleId><ArticleId IdType="pubmed">7762289</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer B.J., Schmaljohn C. Accumulation of Terminally Deleted RNAs May Play a Role in Seoul Virus Persistence. J. Virol. 2000;74:1321–1331. doi: 10.1128/JVI.74.3.1321-1331.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.3.1321-1331.2000</ArticleId><ArticleId IdType="pmc">PMC111467</ArticleId><ArticleId IdType="pubmed">10627543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zani L., Forth J.H., Forth L., Nurmoja I., Leidenberger S., Henke J., Carlson J., Breidenstein C., Viltrop A., Höper D., et al. Deletion at the 5’-End of Estonian ASFV Strains Associated with an Attenuated Phenotype. Sci. Rep. 2018;8:6510. doi: 10.1038/s41598-018-24740-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24740-1</ArticleId><ArticleId IdType="pmc">PMC5916933</ArticleId><ArticleId IdType="pubmed">29695831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamma H., Portman D.S., Dreyfuss G. Cell Type-Specific Expression of HnRNP Proteins. Exp. Cell Res. 1995;221:187–196. doi: 10.1006/excr.1995.1366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1995.1366</ArticleId><ArticleId IdType="pubmed">7589244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertel K.J., Brunner J.E., Semler B.L. Mechanistic Consequences of HnRNP C Binding to Both RNA Termini of Poliovirus Negative-Strand RNA Intermediates. J. Virol. 2010;84:4229–4242. doi: 10.1128/JVI.02198-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02198-09</ArticleId><ArticleId IdType="pmc">PMC2863767</ArticleId><ArticleId IdType="pubmed">20164237</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner J.E., Nguyen J.H.C., Roehl H.H., Ho T.V., Swiderek K.M., Semler B.L. Functional Interaction of Heterogeneous Nuclear Ribonucleoprotein C with Poliovirus RNA Synthesis Initiation Complexes. J. Virol. 2005;79:3254–3266. doi: 10.1128/JVI.79.6.3254-3266.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.6.3254-3266.2005</ArticleId><ArticleId IdType="pmc">PMC1075716</ArticleId><ArticleId IdType="pubmed">15731220</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner J.E., Ertel K.J., Rozovics J.M., Semler B.L. Delayed Kinetics of Poliovirus RNA Synthesis in a Human Cell Line with Reduced Levels of HnRNP C Proteins. Virology. 2010;400:240–247. doi: 10.1016/j.virol.2010.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.01.031</ArticleId><ArticleId IdType="pmc">PMC2844484</ArticleId><ArticleId IdType="pubmed">20189623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vartanian J.-P., Henry M., Marchio A., Suspène R., Aynaud M.-M., Guétard D., Cervantes-Gonzalez M., Battiston C., Mazzaferro V., Pineau P., et al. Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis. PLoS Pathog. 2010;6:e1000928. doi: 10.1371/journal.ppat.1000928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000928</ArticleId><ArticleId IdType="pmc">PMC2877740</ArticleId><ArticleId IdType="pubmed">20523896</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenglein M.D., Burns M.B., Li M., Lengyel J., Harris R.S. APOBEC3 Proteins Mediate the Clearance of Foreign DNA from Human Cells. Nat. Struct. Mol. Biol. 2010;17:222–229. doi: 10.1038/nsmb.1744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1744</ArticleId><ArticleId IdType="pmc">PMC2921484</ArticleId><ArticleId IdType="pubmed">20062055</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E., Perales C. Viral Quasispecies. PLoS Genet. 2019;15:e1008271. doi: 10.1371/journal.pgen.1008271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008271</ArticleId><ArticleId IdType="pmc">PMC6797082</ArticleId><ArticleId IdType="pubmed">31622336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesti-Costa R., Françozo M.C.S., Silva G.K., Proenca-Modena J.L., Silva J.S. TLR3 Is Required for Survival Following Coxsackievirus B3 Infection by Driving T Lymphocyte Activation and Polarization: The Role of Dendritic Cells. PLoS ONE. 2017;12:e0185819. doi: 10.1371/journal.pone.0185819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185819</ArticleId><ArticleId IdType="pmc">PMC5626506</ArticleId><ArticleId IdType="pubmed">28973047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbea C., Makar K.A., Pauschinger M., Pratt G., Bersola J.L.F., Varela J., David R.M., Banks L., Huang C.-H., Li H., et al. A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy. J. Biol. Chem. 2010;285:23208–23223. doi: 10.1074/jbc.M109.047464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.047464</ArticleId><ArticleId IdType="pmc">PMC2906314</ArticleId><ArticleId IdType="pubmed">20472559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng C.T., Oldstone M.B.A. IL-10: Achieving Balance during Persistent Viral Infection. In: Fillatreau S., O’Garra A., editors. Interleukin-10 in Health and Disease. Volume 380. Springer; Berlin/Heidelberg, Germany: 2014. pp. 129–144. Current Topics in Microbiology and Immunology.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004816</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J. Interferon Cytokine Res. 2009;29:313–326. doi: 10.1089/jir.2008.0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2008.0027</ArticleId><ArticleId IdType="pmc">PMC2755091</ArticleId><ArticleId IdType="pubmed">19441883</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F., Mayer-Barber K., Sher A., Wack A., O’Garra A. Type I Interferons in Infectious Disease. Nat. Rev. Immunol. 2015;15:87–103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber F., Kochs G., Haller O. Inverse Interference: How Viruses Fight the Interferon System. Viral Immunol. 2004;17:498–515. doi: 10.1089/vim.2004.17.498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.498</ArticleId><ArticleId IdType="pubmed">15671747</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrikov M.I., Dobrikova E.Y., McKay Z.P., Kastan J.P., Brown M.C., Gromeier M. PKR Binds Enterovirus IRESs, Displaces Host Translation Factors, and Impairs Viral Translation to Enable Innate Antiviral Signaling. mBio. 2022;13:e0085422. doi: 10.1128/mbio.00854-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00854-22</ArticleId><ArticleId IdType="pmc">PMC9239082</ArticleId><ArticleId IdType="pubmed">35652592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C., Donnici L., Aghemo A., Balistreri F., Bianco A., Zanoni V., Pagani M., Soffredini R., D’Ambrosio R., Rumi M.G., et al. Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity. PLoS ONE. 2015;10:e0138546. doi: 10.1371/journal.pone.0138546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138546</ArticleId><ArticleId IdType="pmc">PMC4583497</ArticleId><ArticleId IdType="pubmed">26405760</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahour A., Pletnev A., Vazielle-Falcoz M., Rosen L., Lai C.J. Growth-Restricted Dengue Virus Mutants Containing Deletions in the 5’ Noncoding Region of the RNA Genome. Virology. 1995;207:68–76. doi: 10.1006/viro.1995.1052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1052</ArticleId><ArticleId IdType="pubmed">7871753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühl U., Lassner D., von Schlippenbach J., Poller W., Schultheiss H.-P. Interferon-Beta Improves Survival in Enterovirus-Associated Cardiomyopathy. J. Am. Coll. Cardiol. 2012;60:1295–1296. doi: 10.1016/j.jacc.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.06.026</ArticleId><ArticleId IdType="pubmed">23017536</ArticleId></ArticleIdList></Reference><Reference><Citation>Badorff C., Lee G.-H., Lamphear B.J., Martone M.E., Campbell K.P., Rhoads R.E., Knowlton K.U. Enteroviral Protease 2A Cleaves Dystrophin: Evidence of Cytoskeletal Disruption in an Acquired Cardiomyopathy. Nat. Med. 1999;5:320–326. doi: 10.1038/6543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/6543</ArticleId><ArticleId IdType="pubmed">10086389</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden M.Y., Fukui K., Hosokawa Y., Iwahashi H., Imagawa A., Shimomura I. Examination of a Viral Infection Mimetic Model in Human IPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue. PLoS ONE. 2015;10:e0144606. doi: 10.1371/journal.pone.0144606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144606</ArticleId><ArticleId IdType="pmc">PMC4676675</ArticleId><ArticleId IdType="pubmed">26659307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Bertin A., Sane F., Gimeno J.-P., Fournier I., Salzet M., Engelmann I., Alidjinou E.K., Hober D. Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation. Microorganisms. 2021;9:1125. doi: 10.3390/microorganisms9061125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061125</ArticleId><ArticleId IdType="pmc">PMC8224704</ArticleId><ArticleId IdType="pubmed">34067388</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.-K., Peter A.K., Xiong D., Narezkina A., Yung A., Dalton N.D., Hwang K.-K., Yajima T., Chen J., Knowlton K.U. Inhibition of Coxsackievirus-Associated Dystrophin Cleavage Prevents Cardiomyopathy. J. Clin. Investig. 2013;123:5146–5151. doi: 10.1172/JCI66271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66271</ArticleId><ArticleId IdType="pmc">PMC3859391</ArticleId><ArticleId IdType="pubmed">24200690</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong D., Lee G.-H., Badorff C., Dorner A., Lee S., Wolf P., Knowlton K.U. Dystrophin Deficiency Markedly Increases Enterovirus-Induced Cardiomyopathy: A Genetic Predisposition to Viral Heart Disease. Nat. Med. 2002;8:872–877. doi: 10.1038/nm737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm737</ArticleId><ArticleId IdType="pubmed">12118246</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., Sané F., Engelmann I., Geenen V., Hober D. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov. Med. 2014;18:273–282.</Citation><ArticleIdList><ArticleId IdType="pubmed">25425468</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L., Edwin B., Buanes T., Frisk G., Skog O., Anagandula M., Korsgren O., Undlien D., Eike M.C., Richardson S.J., et al. Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes. Diabetes. 2015;64:1682–1687. doi: 10.2337/db14-1370.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne J.L., Richardson S.J., Atkinson M.A., Craig M.E., Dahl-Jørgensen K., Flodström-Tullberg M., Hyöty H., Insel R.A., Lernmark A., Lloyd R.E., et al. Rationale for Enteroviral Vaccination and Antiviral Therapies in Human Type 1 Diabetes. Diabetologia. 2019;62:744–753. doi: 10.1007/s00125-019-4811-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId><ArticleId IdType="pmc">PMC6450860</ArticleId><ArticleId IdType="pubmed">30675626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>